Sign in
4/A

Changes in Ownership

Keros Therapeutics, Inc. Filed Acc 0002081460-26-000007

Options or other derivatives

  • Chief Legal Officer acquired 80,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Cho Esther · Chief Legal Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-02-24 Grant or award : show line 1 in the form Employee Stock Option (Right to Buy) +80,000 80,000 D
Loading xslF345X06/form4a-03272026_040301.xml…